Gilead Sciences Inc (GILD)
66.94
-0.37
(-0.55%)
USD |
NASDAQ |
Apr 17, 16:00
67.01
+0.07
(+0.10%)
Pre-Market: 08:02
Gilead Sciences Shareholders Equity (Quarterly): 22.83B for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 22.83B |
September 30, 2023 | 22.31B |
June 30, 2023 | 21.16B |
March 31, 2023 | 21.00B |
December 31, 2022 | 21.24B |
September 30, 2022 | 21.08B |
June 30, 2022 | 20.24B |
March 31, 2022 | 19.93B |
December 31, 2021 | 21.07B |
September 30, 2021 | 21.47B |
June 30, 2021 | 19.70B |
March 31, 2021 | 18.95B |
December 31, 2020 | 18.20B |
September 30, 2020 | 17.44B |
June 30, 2020 | 18.03B |
March 31, 2020 | 22.07B |
December 31, 2019 | 22.52B |
September 30, 2019 | 20.60B |
June 30, 2019 | 22.62B |
March 31, 2019 | 21.95B |
December 31, 2018 | 21.39B |
September 30, 2018 | 22.86B |
June 30, 2018 | 21.67B |
March 31, 2018 | 20.59B |
December 31, 2017 | 20.44B |
Date | Value |
---|---|
September 30, 2017 | 24.84B |
June 30, 2017 | 22.68B |
March 31, 2017 | 20.44B |
December 31, 2016 | 18.89B |
September 30, 2016 | 16.87B |
June 30, 2016 | 15.54B |
March 31, 2016 | 13.40B |
December 31, 2015 | 18.53B |
September 30, 2015 | 17.41B |
June 30, 2015 | 16.29B |
March 31, 2015 | 17.18B |
December 31, 2014 | 15.43B |
September 30, 2014 | 13.57B |
June 30, 2014 | 16.09B |
March 31, 2014 | 13.39B |
December 31, 2013 | 11.37B |
September 30, 2013 | 10.88B |
June 30, 2013 | 11.09B |
March 31, 2013 | 10.15B |
December 31, 2012 | 9.303B |
September 30, 2012 | 8.604B |
June 30, 2012 | 8.002B |
March 31, 2012 | 7.314B |
December 31, 2011 | 6.739B |
September 30, 2011 | 6.117B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
17.44B
Minimum
Sep 2020
22.83B
Maximum
Dec 2023
20.66B
Average
21.07B
Median
Dec 2021
Shareholders Equity (Quarterly) Benchmarks
Amgen Inc | 6.232B |
Johnson & Johnson | 68.77B |
Eli Lilly and Co | 10.77B |
CymaBay Therapeutics Inc (DELISTED) | 292.26M |
Arcus Biosciences Inc | 462.00M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 62.12B |
Total Liabilities (Quarterly) | 39.38B |
Debt to Equity Ratio | 1.094 |
Current Ratio | 1.426 |
Net Debt Paydown Yield | 0.05% |